16:35 EDT Aurinia Pharmaceuticals trading resumes
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AUPH:
- Aurinia Soars on Roping In JP Morgan for Strategic Alternatives
- Aurinia Pharmaceuticals: NICE recommends Lupkynis for adults with active LN
- Aurinia says ISS recommends holders vote for company’s board nominees
- Aurinia Pharmaceuticals announces Swissmedic approval of Lupkynis
- Aurinia Pharmaceuticals price target raised to $13 from $11 at RBC Capital